Published in Proc Natl Acad Sci U S A on September 30, 2002
Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J (2003) 3.58
Transcriptional regulation by p53. Cold Spring Harb Perspect Biol (2010) 3.16
ROS and p53: a versatile partnership. Free Radic Biol Med (2008) 2.52
The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal (2009) 2.43
Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy. Antioxid Redox Signal (2012) 2.05
Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal (2009) 1.81
Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol Cell Biol (2003) 1.41
Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis (2013) 1.31
Redox regulation of DNA repair: implications for human health and cancer therapeutic development. Antioxid Redox Signal (2010) 1.31
Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res (2008) 1.25
Redox regulatory mechanisms in cellular stress responses. Ann Bot (2006) 1.22
Transcriptional regulation of the base excision repair pathway by BRCA1. J Biol Chem (2010) 1.16
Selenium and the prevention of prostate and colorectal cancer. Mol Nutr Food Res (2008) 1.14
Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol Cancer Ther (2006) 1.13
APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic Res (2008) 1.13
Cysteine 64 of Ref-1 is not essential for redox regulation of AP-1 DNA binding. Mol Cell Biol (2003) 1.11
Versatile functions of p53 protein in multicellular organisms. Biochemistry (Mosc) (2007) 1.11
Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prev Res (Phila) (2009) 1.09
Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res (2006) 1.05
Advances in carcinogenic metal toxicity and potential molecular markers. Int J Mol Sci (2011) 1.05
Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr (2007) 1.02
Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis. Dose Response (2009) 1.02
Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet (2006) 1.01
Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements. Eur J Nutr (2008) 1.00
APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions. Exp Mol Med (2014) 0.97
New careers for antioxidants. Proc Natl Acad Sci U S A (2002) 0.95
Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function. Mol Biol Cell (2011) 0.94
Biological Effects of Space Radiation and Development of Effective Countermeasures. Life Sci Space Res (Amst) (2014) 0.94
The role of tumor suppressor p53 in the antioxidant defense and metabolism. Subcell Biochem (2014) 0.90
p53, aerobic metabolism, and cancer. Antioxid Redox Signal (2011) 0.90
Mitochondrial superoxide dismutase--signals of distinction. Anticancer Agents Med Chem (2011) 0.90
Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage. J Clin Invest (2015) 0.87
A novel chemopreventive mechanism of selenomethionine: enhancement of APE1 enzyme activity via a Gadd45a, PCNA and APE1 protein complex that regulates p53-mediated base excision repair. Oncol Rep (2013) 0.86
p53 in the DNA-Damage-Repair Process. Cold Spring Harb Perspect Med (2016) 0.86
Gene expression profiling reveals differential effects of sodium selenite, selenomethionine, and yeast-derived selenium in the mouse. Genes Nutr (2011) 0.86
Watching the watcher: regulation of p53 by mitochondria. Future Oncol (2009) 0.85
p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype. PLoS One (2009) 0.84
Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up. BMC Cancer (2011) 0.83
Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention? Mutagenesis (2012) 0.82
Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Biochem Pharmacol (2006) 0.82
Selenium variation induced oxidative stress regulates p53 dependent germ cell apoptosis: plausible involvement of HSP70-2. Eur J Nutr (2009) 0.82
DNA Repair and Cancer Therapy: Targeting APE1/Ref-1 Using Dietary Agents. J Oncol (2012) 0.81
Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus. Int J Mol Sci (2016) 0.80
Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells. J Biol Chem (2008) 0.80
Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells. Free Radic Res (2012) 0.80
Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast. Biochemistry (2009) 0.80
Protective effects of selenocystine against γ-radiation-induced genotoxicity in Swiss albino mice. Radiat Environ Biophys (2011) 0.79
Reduction of gene repair by selenomethionine with the use of single-stranded oligonucleotides. BMC Mol Biol (2007) 0.77
The "Two faces" of Tumor Suppressor p53-revisited. Mol Cell Pharmacol (2010) 0.76
Protective effects of L-selenomethionine on space radiation induced changes in gene expression. Radiat Environ Biophys (2007) 0.76
Mitigating effects of L-selenomethionine on low-dose iron ion radiation-induced changes in gene expression associated with cellular stress. Oncol Lett (2013) 0.76
Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial. Radiat Oncol (2013) 0.75
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell (1992) 19.87
Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci U S A (1999) 7.29
p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol (2000) 6.23
Thioredoxin and thioredoxin reductase. Methods Enzymol (1995) 4.06
Going APE over ref-1. Mutat Res (2000) 3.63
Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res (1999) 3.05
Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev (1997) 2.70
Removal of oxygen free-radical-induced 5',8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc Natl Acad Sci U S A (2000) 2.24
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res (1995) 2.00
Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene (1995) 2.00
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res (1996) 1.93
Role of cysteine residues in regulation of p53 function. Mol Cell Biol (1995) 1.91
Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem (1999) 1.83
Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci U S A (2000) 1.80
Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J (1999) 1.59
Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation. Cancer Res (1998) 1.48
BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. J Biol Chem (2002) 1.45
Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A (1997) 1.33
Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett (1998) 1.32
p53 regulation of DNA excision repair pathways. Mutagenesis (2002) 1.28
Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett (2001) 1.25
The causes and prevention of cancer: gaining perspective. Environ Health Perspect (1997) 1.25
Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog (1999) 1.13
Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr (1999) 1.11
p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts. Cancer Res (1998) 1.11
Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med (1999) 1.10
Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J Biol Chem (1998) 1.09
Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Cancer Res (2001) 1.08
Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene (2002) 1.03
Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol (1995) 1.00
Selenium and prostate cancer prevention. Semin Urol Oncol (1999) 0.96
Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res (1981) 0.95
Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis (1998) 0.95
Development of a sensitive assay to detect reversibly oxidized protein cysteine sulfhydryl groups. Antioxid Redox Signal (2001) 0.95
Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett (1996) 0.93
Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice. Cancer Res (1999) 0.92
p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. Cancer Res (2000) 0.90
Decreased DNA repair efficiency by loss or disruption of p53 function preferentially affects removal of cyclobutane pyrimidine dimers from non-transcribed strand and slow repair sites in transcribed strand. J Biol Chem (2000) 0.85
Chemoprevention of colon carcinogenesis by dietary organoselenium, benzylselenocyanate, in F344 rats. Cancer Res (1987) 0.82
Selenium-enriched Agaricus bisporus mushrooms suppress 7,12-dimethlybenz[a]anthracene bioactivation in mammary tissue. Cancer Lett (1999) 0.78
The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal (2005) 2.75
The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal (2009) 2.43
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med (2007) 2.01
Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther (2004) 1.99
Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol (2003) 1.70
The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. DNA Repair (Amst) (2005) 1.64
Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. J Biol Chem (2005) 1.62
DNA repair in neurons: so if they don't divide what's to repair? Mutat Res (2006) 1.61
Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. Clin Cancer Res (2007) 1.60
Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal (2008) 1.58
APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. Mol Cell Biol (2009) 1.58
Advance care planning: Beyond the living will. Cleve Clin J Med (2009) 1.51
Conditional targeting of the DNA repair enzyme hOGG1 into mitochondria. J Biol Chem (2002) 1.34
Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res (2005) 1.33
Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. Mol Cancer Ther (2004) 1.33
Enhanced mtDNA repair capacity protects pulmonary artery endothelial cells from oxidant-mediated death. Am J Physiol Lung Cell Mol Physiol (2002) 1.32
Redox regulation of DNA repair: implications for human health and cancer therapeutic development. Antioxid Redox Signal (2010) 1.31
Targeting human 8-oxoguanine glycosylase to mitochondria of oligodendrocytes protects against menadione-induced oxidative stress. Glia (2003) 1.27
Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells. J Pharmacol Exp Ther (2010) 1.27
Going ape as an approach to cancer therapeutics. Antioxid Redox Signal (2009) 1.25
Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res (2008) 1.25
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics (2009) 1.23
Ape1 regulates hematopoietic differentiation of embryonic stem cells through its redox functional domain. Blood (2006) 1.22
Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res (2004) 1.22
Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) (2007) 1.18
Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing. Cancer Res (2003) 1.17
Implication of p53 in base excision DNA repair: in vivo evidence. Oncogene (2002) 1.14
Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents. Cancer Res (2005) 1.12
Interactions of apurinic/apyrimidinic endonuclease with a redox inhibitor: evidence for an alternate conformation of the enzyme. Biochemistry (2010) 1.10
National practices regarding payment to research subjects for participating in pediatric research. Pediatrics (2002) 1.09
Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Oncol Rep (2001) 1.08
Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: use of APE1 small molecule inhibitors to delineate APE1 functions. DNA Repair (Amst) (2009) 1.07
Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1). J Med Chem (2010) 1.07
Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress. J Pharmacol Exp Ther (2008) 1.06
Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene (2002) 1.03
Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther (2007) 1.02
Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress. J Cell Physiol (2007) 1.01
Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther (2011) 1.00
Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression. Cancer Invest (2010) 1.00
Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance. Clin Cancer Res (2003) 0.99
The repair function of the multifunctional DNA repair/redox protein APE1 is neuroprotective after ionizing radiation. DNA Repair (Amst) (2011) 0.98
Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res (2006) 0.98
Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: evidence for an autoregulatory loop. Free Radic Res (2005) 0.98
Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo. Vision Res (2010) 0.96
Impact of a palliative care service on in-hospital mortality in a comprehensive cancer center. J Palliat Med (2006) 0.95
Knock-in reconstitution studies reveal an unexpected role of Cys-65 in regulating APE1/Ref-1 subcellular trafficking and function. Mol Biol Cell (2011) 0.94
A systematic review of activities at a high-volume ethics consultation service. J Clin Ethics (2011) 0.92
Characterization of the redox activity and disulfide bond formation in apurinic/apyrimidinic endonuclease. Biochemistry (2012) 0.92
Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis. Exp Hematol (2010) 0.91
Protection of human lung cells against hyperoxia using the DNA base excision repair genes hOgg1 and Fpg. Am J Respir Crit Care Med (2002) 0.91
Practical guidance for charting ethics consultations. HEC Forum (2014) 0.90
APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival. PLoS One (2012) 0.90
Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited. Biochemistry (2013) 0.89
Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells. Am J Physiol Lung Cell Mol Physiol (2002) 0.87
Targeting DNA repair proteins to mitochondria. Methods Mol Biol (2002) 0.86
Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiation. Future Oncol (2009) 0.86
Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain. J Biol Chem (2002) 0.85
Protection of pulmonary epithelial cells from oxidative stress by hMYH adenine glycosylase. Respir Res (2004) 0.84
Semi-automated high-throughput fluorescent intercalator displacement-based discovery of cytotoxic DNA binding agents from a large compound library. Bioorg Med Chem Lett (2010) 0.84
The Xpc gene markedly affects cell survival in mouse bone marrow. Mutagenesis (2009) 0.84
Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines. PLoS One (2013) 0.83
Apurinic/Apyrimidinic endonuclease 1 regulates inflammatory response in macrophages. Anticancer Res (2011) 0.83
Drosophila S3 ribosomal protein accelerates repair of 8-oxoguanine performed by human and mouse cell extracts. Environ Mol Mutagen (2003) 0.82
Repression of cyclin D1 as a target for germ cell tumors. Int J Oncol (2007) 0.82
On being an authentic scientist. IRB (1993) 0.82
Accelerated repair and reduced mutagenicity of oxidative DNA damage in human bladder cells expressing the E. coli FPG protein. Int J Cancer (2006) 0.82
Yeast apurinic/apyrimidinic endonuclease Apn1 protects mammalian neuronal cell line from oxidative stress. J Neurochem (2007) 0.81
Sensitivity of p53-deficient cells to oxaliplatin and thio-TEPA (N, N', N" triethylenethiophosphoramide). Breast Cancer Res Treat (2002) 0.81
Base excision repair apurinic/apyrimidinic endonucleases in apicomplexan parasite Toxoplasma gondii. DNA Repair (Amst) (2011) 0.80
[Effect of adenoviral N-methylpurine DNA glycosylase overexpression on chemosensitivity of human osteosarcoma cells]. Zhonghua Bing Li Xue Za Zhi (2006) 0.80
Preparing for the inevitable: the death of a living liver donor. Liver Transpl (2013) 0.80
Human-yeast chimeric repair protein protects mammalian cells against alkylating agents: enhancement of MGMT protection. Cancer Gene Ther (2003) 0.79
Advance directives, due process, and medical futility. Ann Intern Med (2004) 0.78
Selenomethionine or methylseleninic acid inhibits mutagenesis of a reporter gene in mouse bone marrow. Anticancer Res (2010) 0.78
Mad2 haploinsufficiency protects hematopoietic progenitor cells subjected to cell-cycle stress in vivo and to inhibition of redox function of Ape1/Ref-1 in vitro. Exp Hematol (2011) 0.78
RB stabilizes XPC and promotes cellular NER. Anticancer Res (2010) 0.78
Role of Ape1 and base excision repair in the radioresponse and heat-radiosensitization of HeLa Cells. Anticancer Res (2009) 0.78
Effect of S. cerevisiae APN1 protein on mammalian DNA base excision repair. Anticancer Res (2003) 0.78
Wide variation in content of inpatient do-not-resuscitate order forms used at National Cancer Institute-designated cancer centers in the United States. Support Care Cancer (2008) 0.78
Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications. Future Oncol (2007) 0.76
Challenges in outpatient end-of-life care: wishes to avoid resuscitation. J Clin Oncol (2004) 0.76
Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice. Pancreas (2015) 0.76
A radiation-induced acute apoptosis involving TP53 and BAX precedes the delayed apoptosis and neoplastic transformation of CGL1 human hybrid cells. Radiat Res (2005) 0.76
Case study. Bad words. Commentary. Hastings Cent Rep (2014) 0.75
Case study. All for one, or one for all? Commentary. Hastings Cent Rep (2007) 0.75
Case study. A second chance. Commentary. Hastings Cent Rep (2013) 0.75
Clarification of the intent of ventricular assist devices before patient consent. J Thorac Cardiovasc Surg (2013) 0.75
Identification of the human HEX1/hExo1 gene promoter and characterization of elements responsible for promoter activity. DNA Repair (Amst) (2003) 0.75
Living donor liver transplantation: ethical considerations. Mt Sinai J Med (2012) 0.75
Desperately seeking a surrogate - for a patient lacking decision-making capacity. Narrat Inq Bioeth (2014) 0.75
Effect of S. cerevisiae APN1 protein on mammalian DNA base excision repair. Anticancer Res (2003) 0.75
Ethics of transparency in research reports. Indian J Med Ethics (2011) 0.75
HCEC pearls and pitfalls: suggested do's and don't's for healthcare ethics consultants. J Clin Ethics (2012) 0.75
Power, advocacy, and informed consent forms. J Calif Alliance Ment Ill (1994) 0.75
Repair of 8 oxoguanine in mammalian cells expressing the Drosophila S3 ribosomal/repair protein. Teratog Carcinog Mutagen (2003) 0.75
"Systematizing" ethics consultation services. HEC Forum (2015) 0.75